IHC of proliferative, cancer specific, vascular targeting, inflammatory molecules, including c-Met, Ki-67, VEGFA, cluster of differentiation 31 (CD31), and iNOS, were scored based on an inspection by a pathologist and relevant references (Fig 1B, S4 Fig in S1 File) [17, 38, 39]. This evidence concerns the gene MET and cancer.